OraSure Technologies (OSUR)
(Real Time Quote from BATS)
$4.33 USD
+0.10 (2.36%)
Updated Aug 6, 2024 02:00 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Price, Consensus and EPS Surprise
OSUR 4.33 +0.10(2.36%)
Will OSUR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OSUR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OSUR
OraSure Technologies (OSUR) Q1 Earnings Meet Estimates
Insulet (PODD) Surpasses Q4 Earnings and Revenue Estimates
OSUR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Baxter International (BAX) Tops Q4 Earnings and Revenue Estimates
Abbott (ABT) Q4 Earnings Match Estimates
Zacks.com featured highlights Otter Tail, OraSure, BioMarin and Regeneron
Other News for OSUR
Here is the next potential market catalyst
OraSure Technologies Q2 2024 Earnings Preview
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
OraSure Technologies Supports National HIV Testing Day
OraSure supports HIV testing initiatives for National HIV Testing Day